Nevro Corp (1N7.SG)
- GuruFocus.com
Nevro Corp (NVRO) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of Financial ...
Exploring Nevro Corp's revenue growth, strategic restructuring, and the integration of new business segments in the first quarter of 2024.
- Zacks
Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates
Nevro (NVRO) delivered earnings and revenue surprises of 31.37% and 3.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
Nevro Reports First-Quarter 2024 Financial Results
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its first quarter 2024 financial results. The company also announced additional restructuring steps to advance its strategy and accelerate profitability, raised its adjusted EBITDA guidance and reaffirmed its revenue guidance for the full-year 2024, and announced that Christofer Christoforou has been promoted to the newly created Ch
